India awaits WHO information on any cough syrup link to Gambia deaths

AFP

India is awaiting World Health Organisation (WHO) evidence of a link between an Indian cough syrup and the deaths of dozens of children in Gambia after the UN agency said the medicine may cause kidney damage.

The death of 66 children in the West African country is a blow to India's image as a "pharmacy of the world" that supplies medicines to all continents, especially Africa.

"Urgent investigation in the matter has been already taken up ... immediately after receiving communication from WHO based on the available information," said one of two health ministry staff members who spoke to Reuters on behalf of the ministry but did not want to be identified.

"While all required steps will be taken in the matter", India was awaiting a report establishing "causal relation to death with the medical products in question" and other details from the WHO.

WHO Director-General Tedros Adhanom Ghebreyesus on Wednesday told reporters the UN agency was investigating the deaths from acute kidney injuries with India's drug regulator and New Delhi-based cough syrup manufacturer Maiden Pharmaceuticals.

The UN health agency informed the Drugs Controller General of India of the deaths late last month after which the regulator launched an investigation with state authorities, in tandem with the WHO, the two sources said.

The WHO said laboratory analysis of Maiden cough syrup had confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury.

Telephone calls to a listed number for Maiden, which launched its operations in November 1990, went unanswered as did an emailed request for comment. Calls to the Drugs Controller General of India also went unanswered.

Maiden manufactured and exported the syrup only to Gambia, the Indian ministry sources said. Maiden says on its website it has two manufacturing plants, in Kundli and Panipat, both near New Delhi in Haryana state, and has recently set up another one.

It has an annual production capacity of 2.2 million syrup bottles, 600 million capsules, 18 million injections, 300,000 ointment tubes and 1.2 billion tablets. It says it sells its products at home and exports to countries in Asia, Africa and Latin America.

The two health ministry sources said that importing countries typically test such products before allowing their use.

The WHO said the Maiden products - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup - may have been distributed elsewhere through informal markets but it had only been identified in Gambia.

More from International

  • Thousands of Australians without power as cyclone Alfred hits

    Hundreds of thousands of people in Australia's Queensland state were without power on Sunday after Alfred, a downgraded tropical cyclone, brought damaging winds and heavy rains, sparking flood warnings.

  • Israeli airstrike kills two in southern Gaza

    An Israeli airstrike killed two Palestinians in Rafah in the southern Gaza Strip on Saturday, medical sources said, as mediators pushed ahead with talks to extend a shaky 42-day ceasefire agreed in January between Israel and Hamas.

  • 12 people injured in Toronto pub shooting

    Toronto Police said early on Saturday they were searching for three male suspects in a shooting that injured at least 12 people at a pub in the Canadian city.

  • Cyclone Alfred downgraded as millions stay indoors

    Ex-tropical cyclone Alfred lingered off the south-east Australian coast on Saturday and forecasters said Brisbane is likely to miss the worst of the storm, a relief for millions of residents in the region who have been staying indoors.

  • South Korea's President Yoon free, trials continue

    South Korean President Yoon Suk Yeol walked out of a detention centre in Seoul on Saturday after prosecutors decided not to appeal a court decision to cancel the impeached leader's arrest warrant on insurrection charges.

Coming Up on Dubai Eye

  • The Business Breakfast

    6:00am - 10:00am

    The Business Breakfast is the day’s must listen for the UAE’s business leaders, and those who aspire to be.

  • The Agenda

    10:00am - 1:00pm

    Broadcasting every weekday, Georgia Tolley goes beyond the headlines to speak to government ministers, decision makers, analysts and local experts to find out how the news will impact those of us living in the UAE.

BUSINESS BREAKFAST LATEST

On Dubai Eye

  • Is There Sufficient House Supply In UAE

    Dubai’s current population is more than double compared to almost twenty years ago, which now stands at 3.7 million. Lots of families are also moving to the UAE now. So what does it mean for the property market?

  • Noon's First Female Delivery Driver

    Glory Ehirim Nkiruka is Noon’s first ever female delivery driver. In her first ever interview, she explained why she loves her job, despite the heat!